Management of Atrial Fibrillation With Flecainide : the AFFLEC Study
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT02190175
- Lead Sponsor
- Hellenic Cardiovascular Research Society
- Brief Summary
This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.
- Detailed Description
the study objectives are
* record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation
* study of flecainide in ST interval
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- patients with history of atrial fibrillation
- patients able to give informed consent
- patients with coronary disease or other cardiopathy with left heart champer affected
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ST interval and repolarization measures of myocardia in patients under treatment of flecainide 6months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
Erythros Stavros Hospital
🇬🇷Athens, Greece
University Hospital of Larisa
🇬🇷Larisa, Greece
AHEPA University Hospital
🇬🇷Thessaloniki, Greece
Erythros Stavros Hospital🇬🇷Athens, Greece